Partnership for Applied Research in Fracture Prevention Programs for the Elderly (OPTI-FRAC)
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Tipo de estudio
Tipo de estudio
Inscripción (Actual)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Quebec
-
Amos, Quebec, Canadá, J9T 2S2
- Centre hospitalier Hôtel-Dieu d'Amos
-
Chandler, Quebec, Canadá, G0C 1K0
- CSSS du Roché Percé (Centre hospitalier de Chandler)
-
Gatineau, Quebec, Canadá, J8Y 1W7
- Hôpital de Hull
-
Greenfield Park, Quebec, Canadá, J4V 2H1
- Hôpital Charles LeMoyne
-
Montreal, Quebec, Canadá, H1T 2M4
- Hopital Maisonneuve-Rosemont
-
Montreal, Quebec, Canadá, H4J 1C5
- Hôpital Sacré-Coeur de Montréal
-
Montreal, Quebec, Canadá, H2E1S6
- Hôpital Jean-Talon
-
Saint-Charles-Borromée, Quebec, Canadá, J6E 6J2
- Centre hospitalier régional de Lanaudière
-
Sherbrooke, Quebec, Canadá, J1H5N4
- Centre Hospitalier Universitaire de Sherbrooke
-
St-Jérôme, Quebec, Canadá, J7Z 5T3
- CSSS de St-Jérôme (Hôpital régional de St-Jérôme)
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- 50 years of age and over
- must have a primary care physician
- must be able to follow simple instructions
- must have sustained a fragility fracture within three months of the recruitment date.
Exclusion Criteria:
- severe kidney insufficiency (grade 4 or 5)
- advanced stage of cancer
- fracture to sites not commonly associated with osteoporosis such as toe, finger, hand, foot, ankle, patella, head, and cervical spine.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Sin intervención: Grupo de control
|
|
|
Experimental: Integrated program
Participants will be involved in an integrated interorganisational fragility fracture prevention program, which combines both post-fracture management as well as fall prevention strategies.
The intervention will last up to 18 months.
|
Each participant's primary care physician will receive written information containing a presumed osteoporosis diagnosis, investigations to be performed, correct interpretation of any bone densitometry results in the context of a fragility fracture, and treatment options.
The study coordinator will be responsible for orienting the participant to an appropriate local fall prevention program.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Incidence of secondary fragility fracture
Periodo de tiempo: 18 months post recruitment
|
18 months post recruitment
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Initiation of osteoporosis treatment by the primary care physician
Periodo de tiempo: At 6, 12, 18, and 60 months post recruitment
|
Osteoporosis treatment includes bisphosphonates or other effective osteoporosis drugs.
|
At 6, 12, 18, and 60 months post recruitment
|
|
Compliance with osteoporosis treatment.
Periodo de tiempo: At 6, 12, 18, and 60 months post recruitment
|
The data collected from the participant will be validated with the participant's pharmacist through the medication possession ratio.
The medication possession ratio is measured from the first to the last prescription, with the denominator being the duration from index to the exhaustion of the last prescription and the numerator being the days supplied over that period from first to last prescription and the numerator being the total number of days in the interval.
|
At 6, 12, 18, and 60 months post recruitment
|
|
Time to first fall event
Periodo de tiempo: Within the first 18 months post recruitment
|
Within the first 18 months post recruitment
|
|
|
Incidence of secondary fragility fractures.
Periodo de tiempo: At 24, 36, 48 and 60 months post recruitment
|
At 24, 36, 48 and 60 months post recruitment
|
|
|
Number of clinically significant fall events.
Periodo de tiempo: At 18, 24, 36, 48 and 60 months post recruitment
|
At 18, 24, 36, 48 and 60 months post recruitment
|
|
|
Fall-related hospitalizations
Periodo de tiempo: At 18, 24, 36, 48 and 60 months post recruitment
|
Fall-related hospitalizations will be recorded in the participant diary and at each telephone follow-up, and validated with the participant's hospital records.
|
At 18, 24, 36, 48 and 60 months post recruitment
|
|
Fragility fracture-related death
Periodo de tiempo: At 18, 24, 36, 48 and 60 months post recruitment
|
Fragility fracture-related death will be confirmed from a provincial administrative database (Regie de l'assurance maladie du Quebec - RAMQ).
|
At 18, 24, 36, 48 and 60 months post recruitment
|
|
Participants' quality of life
Periodo de tiempo: At 18, 24, 36, 48 and 60 months post recruitment
|
Euro-QOL
|
At 18, 24, 36, 48 and 60 months post recruitment
|
|
Practice of physical activities
Periodo de tiempo: At 6, 12, 18, 24, 36, 48 and 60 months post recruitment
|
CHAMPS
|
At 6, 12, 18, 24, 36, 48 and 60 months post recruitment
|
|
Fragility fracture-related costs
Periodo de tiempo: At 18 and 60 months post recruitment
|
Medical costs from the participant's hospital record include: medical assessment, prescription and non-prescription drugs; and resource use related to the management of the fragility fracture and/or long-term complications, including hospitalization.
As well, lost days of work, annual income (if the participant is in the labour force), travel to the hospital and/or rehabilitation facilities, parking, and out-of-pocket expenses for drugs and rehabilitation devices (e.g.
splint) will be compiled.
Protocol-driven costs will be excluded, with the exception of the costs related to the participants' fall prevention program.
|
At 18 and 60 months post recruitment
|
|
Admission to a long-term care facility
Periodo de tiempo: At 18, 24, 36, 48 and 60 months post recruitment
|
At 18, 24, 36, 48 and 60 months post recruitment
|
|
|
Participants' perceptions of care integration
Periodo de tiempo: At 12 months post intervention
|
All participants' perceptions of care integration will be captured 12 months after the beginning of the intervention period, or following an early withdrawal from the study.
|
At 12 months post intervention
|
|
Intervention participant's satisfaction with the fragility fracture prevention program
Periodo de tiempo: At 12 months post intervention
|
At 12 months post intervention
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Investigadores
Investigadores
- Investigador principal: Isabelle Gaboury, PhD, Université de Sherbrooke
- Investigador principal: Hélène Corriveau, PhD pht, Université de Sherbrooke
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización primaria
Finalización del estudio (Anticipado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- CIHR grant # 267395
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .